Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Jaime Sánchez-Plumed"'
Autor:
Amparo Pastor, María Jesús Gómez García, Virginia Bosó, Luis Almenar, Enrique Busó, Amparo Solé, José Luis Poveda, Jaime Sánchez-Plumed, Ignacio Sánchez-Lázaro, Sergio Bea, Salvador F. Aliño, Juan Galán, María José Herrero, Martín Prieto
Publikováno v:
Therapeutic Drug Monitoring. 36:159-168
Interpatient variability in drug response can be widely explained by genetically determined differences in metabolizing enzymes, drug transporters, and drug targets, leading to different pharmacokinetic and/or pharmacodynamic behaviors of drugs. Gene
Autor:
Virginia Bosó, María José Herrero, María Galiana, María Remedios Marqués, José Luis Poveda, Patricia Marrero, Julio Hernández, Salvador F. Aliño, Sergio Bea, Jaime Sánchez-Plumed
Publikováno v:
Drug Metabolism and Disposition. 41:480-487
Pharmacogenetics correlates certain genetic variants, such as single nucleotide polymorphisms (SNPs), with blood drug levels, efficacy, and adverse effects of the treatment. Tacrolimus is mainly metabolized via CYP3A4/5, whereas CYP2C19 and CYP3A4/5
Autor:
Juan José Criado-Álvarez, Jaime Sánchez Plumed, Alicia García-Testal, Berta Angélica Bonilla Escobar, Pau Olagüe Díaz
Publikováno v:
Medicina Clínica. 137:335-339
Resumen Fundamento y objetivo El citomegalovirus (CMV) es uno de los agentes patogenos mas importantes en el paciente trasplantado renal. Puede ocasionar infeccion y enfermedad, de graves consecuencias, directas e indirectas. Pacientes y metodo Estud
Autor:
Jaime Sánchez-Plumed, Carlos Jiménez, Daniel Serón, Julio Pascual, Domingo Del Castillo, Francesc Moreso, N. Calvo, F. Anaya
Publikováno v:
NDT Plus
Background. Statin use in renal transplantation has been associated with a lower risk of patient death but not with an improvement of graft functional survival. The aim of this study is to evaluate the effect of statin use in graft survival, death-ce
Autor:
F. Anaya, Federico Oppenheimer, M. Gonzalez-Molina, Jaime Sánchez-Plumed, Domingo Hernández, Francisco B. Ortega, Josep M. Grinyó, Henrik Ekberg, Pablo Rebollo
Publikováno v:
Transplantation. 87:1210-1213
Objective. To evaluate health-related quality of life (HRQoL) in patients with different low-toxicity regimens post-transplantation. Methods. One hundred fifty-six patients were randomized to standard-dose cyclosporine A (CsA), mycophenolate mofetil,
Autor:
Mercè Brunet, Josep M. Grinyó, Richard D. Mamelok, Dirk Kuypers, Henrik Ekberg, Jaime Sánchez-Plumed, Federico Oppenheimer, Domingo Hernández, Miguel A. Gentil
Publikováno v:
Nephrology Dialysis Transplantation. 24:2269-2276
Exposure to mycophenolic acid (MPA), the primary active metabolite of mycophenolate mofetil (MMF), is correlated with therapeutic efficacy of MMF but varies depending on the concomitantly administered immunosuppressive drugs.A 3-month pharmacokinetic
Autor:
Amado, Andrés, Roberto, Marcén, Francisco, Valdés, Jaime Sánchez, Plumed, Ricard, Solà, Pedro, Errasti, Ricardo, Lauzurica, Luis, Pallardó, Jesús, Bustamante, Juan José, Amenábar, Juan José, Plaza, Ernesto, Gómez, Josep Maria, Grinyó, Manuel, Rengel, Josep Maria, Puig, Aurelio, Sanz, Concepción, Asensio, Inés, Andrés, A, Osuna
Publikováno v:
Clinical Transplantation. 23:23-32
This study assays therapy with basiliximab and different patterns of cyclosporin A (CsA) initiation in renal transplant (RT) recipients from expanded criteria donors (ECD) and at high risk of delayed graft function (DGF). A multicentre six-month open
Autor:
Carme Cantarell, Angel Alonso, Antonio Osuna, Miguel A. Gentil, Ricardo Lauzurica, Beatriz Bardají, Josep Vicenç Torregrosa, Javier Paul, Ernesto Gómez Huertas, Domingo Hernández, Ana Fernández, Antonio Franco, Auxiliadora Mazuecos, Juan Carlos Ruiz, Jaime Sánchez Plumed, S. Zarraga, Carlos Jiménez, Dolores Burgos, Alberto Rodriguez, Lluis Guirado
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Transplantation Direct
Consejería de Sanidad de la Comunidad de Madrid
Transplantation Direct
Background There is some evidence pointing toward better renal function in kidney transplant recipients (KTR) treated with once-daily tacrolimus (QD-TAC) vs. twice-daily tacrolimus (BID-TAC). Methods This is an extension study of a 1-year, single arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f7ec7055cc17b0885514a5ea856f6b3
https://hdl.handle.net/20.500.12530/19503
https://hdl.handle.net/20.500.12530/19503
Autor:
Jaime Sánchez-Plumed, Sergio Bea, María José Herrero, Salvador F. Aliño, María Galiana, María Remedios Marqués
Publikováno v:
Transplantation Proceedings. 42:3134-3136
Pharmacogenetics is the study of the cause of various individual responses to the same pharmacologic therapy. Genetic alterations in a single nucleotide in the genes responsible for transport and metabolism of an immunosuppression drug may modify pat
Autor:
Sergio Bea, Julio Hernández, Salvador F. Aliño, María José Herrero, Virginia Bosó, Luis Rojas, José Luis Poveda, Jaime Sánchez Plumed
Publikováno v:
Current Issues and Future Direction in Kidney Transplantation
Optimizing balance between therapeutic efficacy and the occurrence of adverse events is the main goal of individualized medicine. This takes even more importance in narrow therapeutic index drugs such as immunosuppressants. These drugs are highly eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c204a6928f876b44b2b1ba6d7aa8d9
https://doi.org/10.5772/54733
https://doi.org/10.5772/54733